BioE-1115

N/A

Report date: 2022/08/02 14:19:28
NME

Base Information

Drug NameBioE-1115
Drug Alias NameBioE-1115
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPASK inhibitors
TargetsPASK
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSynergenics LLCBioenergenix LLC
China Registration ClassN/A

Develop Information

Active CompaniesBioenergenix LLCSynergenics LLC
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A